Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.
With the city as both setting and subject, AAP's new graduate program prepares students to address pressing urban, environmental, and social issues using the tools of design.
Personal sensing data could help monitor and alleviate stress among resident physicians, although privacy concerns over who sees the information and for what purposes must be addressed, according to collaborative research from Cornell Tech.
The Cornell Board of Trustees and Weill Cornell Medicine Board of Fellows have approved the appointment of Dr. Francis Lee as interim dean of Weill Cornell Medicine and interim provost for medical affairs.
New research offers insight as to why individuals who inherit a mutation in one copy of the BRCA1 gene often develop mutations in their remaining normal copy of the BRCA1 gene, setting the stage for tumors to develop.
A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA vaccines to deter cancer development in at-risk groups.
With the six-month, $1 million grant, Weill Cornell Medicine researchers will assess how countries have been monitoring and reporting COVID-19 infections and outcomes.
The study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease.
